Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone Acetate in Hormone Refractory Prostate Cancer
NCT00473746Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2006
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Abiraterone Acetate Tablets (I) in prostate cancer (PCa), sponsored by Janssen Pharmaceutical. Started Jun 2006; status: completed.
02
Drugs
Abiraterone Acetate Tablets (I)
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00473746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00473746.